Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)
-
Published:2022-04
Issue:S1
Volume:17
Page:
-
ISSN:1750-1172
-
Container-title:Orphanet Journal of Rare Diseases
-
language:en
-
Short-container-title:Orphanet J Rare Dis
Author:
Fiot Elodie, Alauze Bertille, Donadille Bruno, Samara-Boustani Dinane, Houang Muriel, De Filippo Gianpaolo, Bachelot Anne, Delcour Clemence, Beyler Constance, Bois Emilie, Bourrat Emmanuelle, Bui Quoc Emmanuel, Bourcigaux Nathalie, Chaussain Catherine, Cohen Ariel, Cohen-Solal Martine, Da Costa Sabrina, Dossier Claire, Ederhy Stephane, Elmaleh Monique, Iserin Laurence, Lengliné Hélène, Poujol-Robert Armelle, Roulot Dominique, Viala Jerome, Albarel Frederique, Bismuth Elise, Bernard Valérie, Bouvattier Claire, Brac Aude, Bretones Patricia, Chabbert-Buffet Nathalie, Chanson Philippe, Coutant Regis, de Warren Marguerite, Demaret Béatrice, Duranteau Lise, Eustache Florence, Gautheret Lydie, Gelwane Georges, Gourbesville Claire, Grynberg Mickaël, Gueniche Karinne, Jorgensen Carina, Kerlan Veronique, Lebrun Charlotte, Lefevre Christine, Lorenzini Françoise, Manouvrier Sylvie, Pienkowski Catherine, Reynaud Rachel, Reznik Yves, Siffroi Jean-Pierre, Tabet Anne-Claude, Tauber Maithé, Vautier Vanessa, Tauveron Igor, Wambre Sebastien, Zenaty Delphine, Netchine Irène, Polak Michel, Touraine Philippe, Carel Jean-Claude, Christin-Maitre Sophie, Léger JulianeORCID
Abstract
AbstractTurner syndrome (TS; ORPHA 881) is a rare condition in which all or part of one X chromosome is absent from some or all cells. It affects approximately one in every 1/2500 liveborn girls. The most frequently observed karyotypes are 45,X (40–50%) and the 45,X/46,XX mosaic karyotype (15–25%). Karyotypes with an X isochromosome (45,X/46,isoXq or 45,X/46,isoXp), a Y chromosome, X ring chromosome or deletions of the X chromosome are less frequent. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) is to provide health professionals with information about the optimal management and care for patients, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Center for Rare Growth and Developmental Endocrine disorders, is available from the French Health Authority website. Turner Syndrome is associated with several phenotypic conditions and a higher risk of comorbidity. The most frequently reported features are growth retardation with short adult stature and gonadal dysgenesis. TS may be associated with various congenital (heart and kidney) or acquired diseases (autoimmune thyroid disease, celiac disease, hearing loss, overweight/obesity, glucose intolerance/type 2 diabetes, dyslipidemia, cardiovascular complications and liver dysfunction). Most of the clinical traits of TS are due to the haploinsufficiency of various genes on the X chromosome, particularly those in the pseudoautosomal regions (PAR 1 and PAR 2), which normally escape the physiological process of X inactivation, although other regions may also be implicated. The management of patients with TS requires collaboration between several healthcare providers. The attending physician, in collaboration with the national care network, will ensure that the patient receives optimal care through regular follow-up and screening. The various elements of this PNDS are designed to provide such support.
Funder
French National Ministry of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference115 articles.
1. Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1–70. 2. Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, et al. Trends in age at diagnosis of Turner syndrome. Arch Dis Child. 2005;90(3):267–8. 3. Bernard V, Donadille B, Le Poulennec T, Nedelcu M, Martinerie L, Christin-Maitre S. Management of endocrine disease: transition of care for young adult patients with Turner syndrome. Eur J Endocrinol. 2019;180(1):R1–7. 4. Fiot E, Zenaty D, Boizeau P, Haignere J, Santos SD, Leger J, et al. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome. Eur J Endocrinol. 2016;175(3):X1. 5. Lin AE, Prakash SK, Andersen NH, Viuff MH, Levitsky LL, Rivera-Davila M, et al. Recognition and management of adults with Turner syndrome: from the transition of adolescence through the senior years. Am J Med Genet A. 2019;179(10):1987–2033.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|